Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

Switzerland’s president is lobbying Trump administration officials in Washington this week, as concern mounts over the double ...

In today's Pharmalittle roundup, we're reading about Roche and Merck struggles with tariffs, NEJM quizzed by U.S. attorney, ...

Roche has said it is petitioning the Trump administration for an exemption from threatened tariffs for pharmaceuticals, ...

Repertoire will obtain an upfront payment of $35m from Genentech, with the potential for up to $730m in additional milestones ...

The pharmaceutical and diagnostics company slightly exceeded expectations in the first quarter, driven by its pharmaceutical ...

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

Granite Bio is ready to rock ‘n’ roll, unveiling with $100 million and hopes of shaping new antibody treatments targeting ...

During the three-day visit, the Swiss delegation will highlight Switzerland’s substantial investments in the United States, ...

Brabeck-Letmathe, 80, spent his career at Nestlé. He became a controversial figure after sharing his views on water as a ...

Clinical-stage company targeting fundamental drivers of inflammation, autoimmunity and fibrosis, founded by Versant Ventures and Novartis Venture Fund- ...